Skip to main content
Fig. 1 | Virology Journal

Fig. 1

From: SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City

Fig. 1

Sampling across the study period. Two plasma aliquots used for routine HIV viral load follow-up were selected for each participant from January 2020 to September 2021. The time frames of the first and second samples are shown in comparison with the official total number of COVID-19 cases reported in Mexico City during the study period [3]

Back to article page